Click here to close now.

SYS-CON MEDIA Authors: Liz McMillan, Elizabeth White, Dana Gardner, tru welu, Blue Box Blog

News Feed Item

PPD Beach2Battleship Heroes Promote Participation in Clinical Trials

Pharmaceutical Product Development, LLC (PPD) today announced the 2014 PPD Heroes team of athletes competing in the Oct. 25 PPD Beach2Battleship Triathlon, one of the top-rated iron distance events in the world.

PPD Heroes, everyday people who overcame illness with medical treatments developed through clinical research, raise awareness about the importance of increasing participation in clinical trials, which are integral to developing next-generation medicines. PPD Heroes will share their inspirational stories at the PPD Hero Awards, an invitation-only celebration at the company’s world headquarters in Wilmington on Oct. 24, a day before competing in the triathlon.

“PPD Heroes’ remarkable journeys from illness to wellness inspire researchers working tirelessly to develop new medical treatments,” said David Simmons, chairman and CEO of PPD. “Their advocacy to increase understanding about clinical trials is important in helping patients and physicians become aware of innovative treatment options. Increasing participation in clinical trials also helps researchers advance the pace of medical breakthroughs that can improve health and save lives.”

The 2014 team of PPD Heroes features:

  • Wendy Chioji, who was diagnosed with stage 2 breast cancer in 2001. She enrolled in a clinical trial at the urging of her oncologist, who was also her marathon training partner, to potentially help herself while advancing research for others. The resulting chemotherapy successfully treated Wendy’s breast cancer.
  • Tim Fortuna, an emergency room physician and triathlete, felt pain and discomfort in his chest following a long day of training five days after turning 37. Tests revealed a 70 percent blockage of a coronary artery. Cardiologists implanted a drug-eluting stent, which allowed the father of two to return to daily activities and again compete in triathlons.
  • Laura Hull was diagnosed with ulcerative colitis at age 24 and spent 15 years battling the disease and accompanying symptoms. Before a surgical procedure provided relief, she participated in a clinical trial testing new medication to help further the advancement of effective treatments for ulcerative colitis.
  • Mary Kreis, at 23 weeks pregnant, needed surgery to remove a cancerous mole and a sentinel lymph node. Surgeons discovered the cancer had spread, and a second operation removed additional lymph nodes. Thanks to results from previous clinical trials, Mary’s oncologist was confident the procedure was safe for a pregnant patient. Weeks later, Mary gave birth to a healthy baby girl.
  • Meg Roberts, diagnosed with type 1 diabetes at age 10, credits clinical researchers for developing therapies that help her manage the condition. As there is no cure for diabetes, to stay healthy she must inject insulin several times a day. Over the years, clinical research aided the development of insulin and enhanced blood glucose monitoring methods.
  • Chris Samia was diagnosed with psoriasis in the seventh grade. He underwent various types of treatments for the next 15 years and was unable to be physically active because of the painful condition affecting nearly all the skin on his body. At 27 and obese, Chris participated in a clinical trial for a medication that relieved his symptoms and transformed his life, allowing him to lose more than 100 pounds and compete as a triathlete.
  • Emily Schaller, a cystic fibrosis (CF) patient and founder of the Rock CF Foundation, has participated in multiple clinical trials. In 1983, at 18 months old, she was diagnosed with CF at a time when the median age of survival was in the late teens. She began participating in clinical trials in her early teens and has volunteered for trials of breakthrough CF therapies.

PPD is celebrating its fifth year as title sponsor of the PPD Beach2Battleship Triathlon, which has been ranked among the top five triathlons in the world by readers of Triathlete magazine. The race starts in Wrightsville Beach, winds through New Hanover, Pender, Sampson and Bladen counties and ends in downtown Wilmington. The full iron distance triathlon includes a 2.4-mile swim, a 112-mile bike ride and a 26.2-mile run. The event also offers a half iron distance triathlon course.

The PPD Beach2Battleship Triathlon last month announced the addition of the New Hanover Regional Medical Center (NHRMC) 5K to the lineup of race weekend events, providing an expanded opportunity for participation. The NHRMC 5K will be held the morning of the triathlon, starting at 9 a.m. at Legion Stadium, running along the streets of Greenfield Lake and downtown Wilmington, and ending at the PPD Beach2Battleship Triathlon finish line on Water Street.

More than 2,000 athletes participate in the PPD Beach2Battleship Triathlon, helping generate approximately $4 million in local economic impact. Funds raised benefit the Wilmington Family YMCA. PPD Beach2Battleship is produced by Set Up Events, one of the largest triathlon production companies in the United States, producing more than 150 events annually in eight states.

About PPD

PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.

Except for historical information, all of the statements, expectations and assumptions, including statements, expectations and assumptions about the PPD Beach2Battleship Triathlon, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based and could cause actual results to differ materially from the forward-looking statements. Other important factors that could cause future results to differ materially include the following: the ability to attract, integrate, retain and train key personnel; competition in the outsourcing industry; PPD’s ability to win new business; the ability to control SG&A spending; overall global economic conditions; economic conditions, research and development spending, and outsourcing trends in the pharmaceutical, biotechnology and government-sponsored research sectors; loss, delay or modification of large contracts; higher-than-expected cancellation rates; the rate of conversion of backlog into revenue; risks associated with acquisitions and investments; rapid technological advances that make our services or capabilities less competitive; compliance with drug development regulations; changes in the regulation of the drug development process; consolidation in the pharmaceutical and biotechnology industries; risks associated with and dependence on strategic relationships; and actual operating performance. PPD assumes no obligation and expressly disclaims any duty to update these forward-looking statements in the future, except as required by applicable law. These forward-looking statements should not be relied upon as representing PPD’s estimates or views as of any date subsequent to the date hereof.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The Internet of Things promises to transform businesses (and lives), but navigating the business and technical path to success can be difficult to understand. In his session at @ThingsExpo, Sean Lorenz, Technical Product Manager for Xively at LogMeIn, demonstrated how to approach creating broadly successful connected customer solutions using real world business transformation studies including New England BioLabs and more.
Today’s enterprise is being driven by disruptive competitive and human capital requirements to provide enterprise application access through not only desktops, but also mobile devices. To retrofit existing programs across all these devices using traditional programming methods is very costly and time consuming – often prohibitively so. In his session at @ThingsExpo, Jesse Shiah, CEO, President, and Co-Founder of AgilePoint Inc., discussed how you can create applications that run on all mobile ...
The OpenStack cloud operating system includes Trove, a database abstraction layer. Rather than applications connecting directly to a specific type of database, they connect to Trove, which in turn connects to one or more specific databases. One target database is Postgres Plus Cloud Database, which includes its own RESTful API. Trove was originally developed around MySQL, whose interfaces are significantly less complicated than those of the Postgres cloud database. In his session at 16th Cloud...
There are 182 billion emails sent every day, generating a lot of data about how recipients and ISPs respond. Many marketers take a more-is-better approach to stats, preferring to have the ability to slice and dice their email lists based numerous arbitrary stats. However, fundamentally what really matters is whether or not sending an email to a particular recipient will generate value. Data Scientists can design high-level insights such as engagement prediction models and content clusters that a...
It's time to face reality: "Americans are from Mars, Europeans are from Venus," and in today's increasingly connected world, understanding "inter-planetary" alignments and deviations is mission-critical for cloud. In her session at 15th Cloud Expo, Evelyn de Souza, Data Privacy and Compliance Strategy Leader at Cisco Systems, discussed cultural expectations of privacy based on new research across these elements
In today's application economy, enterprise organizations realize that it's their applications that are the heart and soul of their business. If their application users have a bad experience, their revenue and reputation are at stake. In his session at 15th Cloud Expo, Anand Akela, Senior Director of Product Marketing for Application Performance Management at CA Technologies, discussed how a user-centric Application Performance Management solution can help inspire your users with every applicati...
The consumption economy is here and so are cloud applications and solutions that offer more than subscription and flat fee models and at the same time are available on a pure consumption model, which not only reduces IT spend but also lowers infrastructure costs, and offers ease of use and availability. In their session at 15th Cloud Expo, Ermanno Bonifazi, CEO & Founder of Solgenia, and Ian Khan, Global Strategic Positioning & Brand Manager at Solgenia, discussed this shifting dynamic with an ...
As enterprises engage with Big Data technologies to develop applications needed to meet operational demands, new computation fabrics are continually being introduced. To leverage these new innovations, organizations are sacrificing market opportunities to gain expertise in learning new systems. In his session at Big Data Expo, Supreet Oberoi, Vice President of Field Engineering at Concurrent, Inc., discussed how to leverage existing infrastructure and investments and future-proof them against e...
Due of the rise of Hadoop, many enterprises are now deploying their first small clusters of 10 to 20 servers. At this small scale, the complexity of operating the cluster looks and feels like general data center servers. It is not until the clusters scale, as they inevitably do, when the pain caused by the exponential complexity becomes apparent. We've seen this problem occur time and time again. In his session at Big Data Expo, Greg Bruno, Vice President of Engineering and co-founder of StackI...
Once the decision has been made to move part or all of a workload to the cloud, a methodology for selecting that workload needs to be established. How do you move to the cloud? What does the discovery, assessment and planning look like? What workloads make sense? Which cloud model makes sense for each workload? What are the considerations for how to select the right cloud model? And how does that fit in with the overall IT transformation?
The recent trends like cloud computing, social, mobile and Internet of Things are forcing enterprises to modernize in order to compete in the competitive globalized markets. However, enterprises are approaching newer technologies with a more silo-ed way, gaining only sub optimal benefits. The Modern Enterprise model is presented as a newer way to think of enterprise IT, which takes a more holistic approach to embracing modern technologies.
For better or worse, DevOps has gone mainstream. All doubt was removed when IBM and HP threw up their respective DevOps microsites. Where are we on the hype cycle? It's hard to say for sure but there's a feeling we're heading for the "Peak of Inflated Expectations." What does this mean for the enterprise? Should they avoid DevOps? Definitely not. Should they be cautious though? Absolutely. The truth is that DevOps and the enterprise are at best strange bedfellows. The movement has its roots in t...
The true value of the Internet of Things (IoT) lies not just in the data, but through the services that protect the data, perform the analysis and present findings in a usable way. With many IoT elements rooted in traditional IT components, Big Data and IoT isn’t just a play for enterprise. In fact, the IoT presents SMBs with the prospect of launching entirely new activities and exploring innovative areas. CompTIA research identifies several areas where IoT is expected to have the greatest impac...
There is little doubt that Big Data solutions will have an increasing role in the Enterprise IT mainstream over time. 8th International Big Data Expo, co-located with 17th International Cloud Expo - to be held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA - has announced its Call for Papers is open. As advanced data storage, access and analytics technologies aimed at handling high-volume and/or fast moving data all move center stage, aided by the cloud computing bo...
Every day we read jaw-dropping stats on the explosion of data. We allocate significant resources to harness and better understand it. We build businesses around it. But we’ve only just begun. For big payoffs in Big Data, CIOs are turning to cognitive computing. Cognitive computing’s ability to securely extract insights, understand natural language, and get smarter each time it’s used is the next, logical step for Big Data.